Table 1.
Patient characteristics of the overall and genotyped sub-cohort of the CCG-1952 study.
| CCG-1952 |
Overall |
Genotyped |
P | |||
|---|---|---|---|---|---|---|
| Characteristics | N | % | N | % | ||
| n | 2027 | 100.0 | 714 | 100.0 | ||
| Age | 1–1.99 | 165 | 8.1 | 62 | 8.7 | 0.78 |
| 2–5.99 | 1402 | 69.2 | 493 | 69.0 | ||
| 6–9.99 | 460 | 22.7 | 159 | 22.3 | ||
| Sex | Male | 1129 | 55.7 | 375 | 52.5 | 0.03 |
| Female | 898 | 44.3 | 339 | 47.5 | ||
| Race/Ethnicity | White | 1376 | 68.2 | 537 | 75.2 | <0.01 |
| Black | 72 | 3.6 | 23 | 3.2 | ||
| Hispanic | 444 | 22.0 | 98 | 13.7 | ||
| Other | 125 | 6.2 | 56 | 7.8 | ||
| Immunophenotype | B-cell | 1802 | 93.3 | 577 | 95.8 | <0.01 |
| T-cell | 130 | 6.7 | 25 | 4.2 | ||
| Relapse | No | 1693 | 83.5 | 602 | 84.3 | 0.47 |
| Yes | 334 | 16.5 | 112 | 15.7 | ||
Total summations of less than 2027 patients in the overall cohort, or less than 714 patients in the genotyped sub-cohort, are due to missing observations.